71
Views
9
CrossRef citations to date
0
Altmetric
Case Report

Diabetic papillopathy treated with intravitreal ranibizumab

, , &
Pages 99-103 | Published online: 22 Mar 2017

References

  • BayraktarZAlacaliNBayraktarSDiabetic papillopathy in type II diabetic patientsRetina200222675275812476102
  • RegilloCDBrownGCSavinoPJByrnesGABensonWETasmanWSSergottRCDiabetic papillopathy. Patient characteristics and fundus findingsArch Ophthalmol199511378898957605280
  • HayrehSSZimmermanBNonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patientsOphthalmology2008115101818182518502511
  • KimMLeeJHLeeSJDiabetic papillopathy with macular edema treated with intravitreal ranibizumabClin Ophthalmol201372257226024348012
  • Al-HinaiASAl-AbriMSAl-HajriRHDiabetic papillopathy with macular edema treated with intravitreal bevacizumabOman J Ophthalmol20114313513822279402
  • Al-HaddadCEJurdiFABashshurZFIntravitreal triamcinolone acetonide for the management of diabetic papillopathyAm J Ophthalmol200413761151115315183815
  • LubowMMakleyTAJrPseudopapilledema of juvenile diabetes mellitusArch Ophthalmol19718544174225554869
  • AppenREChandraSRKleinRMyersFLDiabetic papillopathyAm J Ophthalmol19809022032097425031
  • OtoSYilmazGCakmakciAAydinPIndocyanine green and fluorescein angiography in nonarteritic anterior ischemic optic neuropathyRetina200222218719111927852
  • WeisSMChereshDAPathophysiological consequences of VEGF-induced vascular permeabilityNature2005437705849750416177780